Three days, twice a day, and signs of withdrawal in the mice
What happened
Researchers at the University of Connecticut have tested a cannabis compound that is sold widely in sleep products, and found results worth knowing about. The compound is cannabinol, usually shortened to CBN. It turns up in sleep gummies, tinctures and capsules, often marketed as the gentle, non-intoxicating option for people who cannot drop off. The team gave CBN to mice twice a day for three consecutive days. Three findings stood out. The mice became less responsive to CBN as the treatment continued. That is tolerance — the same dose doing less. When CBN was withdrawn, the mice showed head twitching and paw fluttering. The researchers compare these to the shaking seen during withdrawal from some drugs in humans. And mice that had previously been trained to recognise THC — the main intoxicating compound in cannabis — responded to CBN in a similar way. That suggests the two overlap in their subjective effects more than the marketing implies. There were findings pointing the other way too. CBN reduced inflammation, including at lower doses that did not produce psychoactive effects. But in a simulated bacterial challenge, it also reduced the body’s ability to defend against infection. The study was published in Drug and Alcohol Dependence, and the University of Connecticut set out the findings in a release reported on 25 October 2026.
Why this matters
CBN products are sold in a gap in most people’s understanding. They are not prescribed medicines, so nobody hands you a leaflet about interactions. They are not quite ordinary food either. They sit on a shelf looking like sweets. The marketing tends to position CBN as the mild cousin of THC: relaxing, sleep-promoting, nothing to worry about. Olivia Vanegas, the study’s lead author, was blunt about the state of that market. “The marketing of minor cannabinoids is pretty wild right now,” she said. That is the real point of this research. It is not that CBN has been shown to be dangerous. It is that a compound being sold at scale, to people taking it nightly, has barely been studied — and the first careful look turns up tolerance and withdrawal signs rather than nothing at all. Steven Kinsey, a professor in UConn’s Elisabeth DeLuca School of Nursing, framed it as a consumer issue: “Our findings suggest consumers should be aware repeated use may carry risks.” The closing message from the team was simply “buyer beware”. The immune finding deserves a particular mention. If you take something nightly through winter, the question of whether it affects your response to infection is not academic.
What the evidence actually says
This was a mouse study, and that limit does most of the work here. It does not show that CBN causes dependence or withdrawal in people. Mice are used precisely because you can control the dose and the timing, but a compound that produces tolerance in a mouse over three days may behave differently in a human taking a gummy at bedtime. The article reports no sample sizes, percentages or statistical results. The only quantitative detail given is the dosing schedule: twice a day for three days. So the strength of each finding is hard to judge from the summary. There are other open questions the researchers name themselves. They do not know how CBN affects sleep quality — which is, after all, the reason people buy it. They do not know whether repeated use at typical supplement doses could lead to addiction in humans. Appropriate doses and long-term effects in people remain unclear. The team also notes CBN may still have genuine therapeutic value. The anti-inflammatory effect at non-psychoactive doses is a real finding, and an interesting one. So the fair reading is not “CBN is harmful”. It is “CBN is less understood than its packaging suggests, and the early signals are worth taking seriously rather than ignoring”. The paper is “Tolerance, physical dependence, and Δ9-THC-like interoceptive effects of cannabinol in mice”, in Drug and Alcohol Dependence.
Qurexa perspective
We deliver prescriptions and support people in keeping on top of their medicines, so we see what actually sits in people’s bathroom cabinets. It is rarely just what the GP prescribed. Supplements bought online are the most common blind spot. People tell their pharmacist about tablets and say nothing about gummies, because gummies do not feel like medicine. The body does not make that distinction. Sleep products are a particular case, because so many of the people buying them already take something sedating — certain painkillers, antihistamines, some antidepressants, or medicines for anxiety. Stacking a second sedating substance on top is the kind of thing worth a two-minute conversation rather than a guess. If you take a CBN product, or are thinking about one, add it to the list you give your pharmacist. Most community pharmacists will look at everything together and tell you whether there is anything to think about. You do not need an appointment and it does not cost anything. And if you are buying sleep products because you consistently cannot sleep, that is worth raising with your GP in its own right. Persistent poor sleep usually has a cause, and treating the cause works better than managing the symptom nightly for years.
What to know
Mice given cannabinol (CBN) twice a day for three days became less responsive to it — a sign of tolerance — and showed head twitching and paw fluttering when it was withdrawn, which researchers compare to withdrawal shaking. Mice trained to recognise THC responded similarly to CBN. CBN also reduced inflammation, including at doses too low to be psychoactive. But in a simulated bacterial challenge it reduced the body’s ability to fight infection. This was a mouse study. It does not establish dependence or withdrawal in people, and the published summary gives no sample sizes or statistical results. Researchers do not yet know how CBN affects sleep quality, what dose is appropriate, or what long-term use does in humans. CBN is sold widely in sleep gummies and similar products with little regulation of those claims. If you take one, tell your pharmacist, especially if you already take anything sedating. If you cannot sleep night after night, that is worth discussing with your GP. Sources: University of Connecticut, “Popular cannabis sleep gummies may have a hidden dark side”, ScienceDaily, 25 October 2026, https://www.sciencedaily.com/releases/2026/10/261024221952.htm; Vanegas, O., Marusich, J. A., Maturano, J., Sarlah, D., and Kinsey, S. G., “Tolerance, physical dependence, and Δ9-THC-like interoceptive effects of cannabinol in mice”, Drug and Alcohol Dependence, 2026, https://doi.org/10.1016/j.drugalcdep.2026.113341 This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional.
Related articles
£432 million more, 2,000 possible bedspaces, and a promise with a date on it
The Government has announced an extra £432 million for rough sleeping, and set a date against the promise. Prime Minister Andy Burnham said he is confident tha…
A consultation opened today, and it closes on 21 December
The Government has opened a consultation on ending the use of high-concentration carbon dioxide to stun pigs in British slaughterhouses. Stunning is the step t…